A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments with Parkinson Medicinal Products, who Continue to

Grants and Contracts Details

StatusFinished
Effective start/end date12/7/098/30/13

Funding

  • Quintiles Inc: $438,252.00